A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/551 (2006.01) A61K 31/137 (2006.01) A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/4412 (2006.01) A61K 31/496 (2006.01) A61K 31/513 (2006.01) A61K 31/55 (2006.01) A61K 31/554 (2006.01) A61P 25/18 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2530381
The invention relates to a medicament which comprises, in a pharmaceutically-acceptable vehicle, an antipsychotic agent or an antidepressant agent (A), the only adverse effect thereof being weight gain or sedation, and an antagonist and/or inverse agonist (B) of histamine receptor H¿3?, said antagonist and/or inverse agonist of histamine receptor H¿3 ?being present in a therapeutically-effective quantity such as to provide at least one of the following three effects: suppression or at least limitation of the adverse weight gain effect, suppression or limitation of the adverse effect on vigilance, epilepsy/convulsions, increase in the pro-cognitive effect of the treatment. The invention also relates to one such antagonist or inverse agonist for the preparation of a medicament that is intended to provide at least one of the aforementioned effects in a patient being treated with one such antipsychotic or antidepressant agent
Médicament comprenant, dans un véhicule pharmaceutiquement acceptable, un anti- psychotique ou un antidépresseur (A), présentant seul un effet indésirable de prise de poids corporel ou de sédation et un antagoniste et/ou agoniste inverse (B) du récepteur H3 de l'histamine, ledit antagoniste et/ou agoniste inverse du récepteur H3 de l'histamine étant présent en une quantité thérapeutiquement efficace pour assurer l'un au moins des trois effets suivants : suppression ou au moins limitation de l'effet indésirable de prise de poids, suppression ou limitation de l'effet indésirable sur la vigilance, épilepsie/convulsions, augmentation de l'effet pro-cognitif du traitement. Utilisation d'un tel antagoniste ou agoniste inverse pour la préparation d'un médicament destiné à assurer l'un au moins desdits trois effets chez un patient traité par un tel antipsychotique ou antidépresseur.
Lecomte Jeanne-Marie
Schwartz Jean-Charles
Bioprojet
Robic
LandOfFree
Combination product comprising an antagonist or inverse... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination product comprising an antagonist or inverse..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination product comprising an antagonist or inverse... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1890733